Literature DB >> 12706090

Human recombinant neutralizing antibodies against hantaan virus G2 protein.

Joachim Koch1, Mifang Liang, Iris Queitsch, Annette A Kraus, Ekkehard K F Bautz.   

Abstract

Old world hantaviruses, causing hemorrhagic fever with renal syndrome (HFRS), still present a public health problem in Asia and Eastern Europe. The majority of cases has been recorded in China. The aim of our study was to generate human recombinant neutralizing antibodies to a hantavirus by phage display technology. To preserve the structural identity of viral protein, the panning procedure was performed on native Hantaan (HTN) (76-118) virus propagated in Vero-E6 cells. In total, five complete human recombinant IgG antibodies were produced in a baculovirus expression system. All of them were able to completely neutralize HTN, and Seoul (SEO) virus in a plaque reduction neutralization test (PRNT). Three of these antibodies could also completely neutralize Dobrava (DOB) virus but not Puumala (PUU) virus. All antibodies bind to Hantaan virus G2 protein localized in the virus envelope. The sequence areas within the HTN (76-118)-G2 protein detected by five selected antibodies were mapped using peptide scans. Two partial epitopes, 916-KVMATIDSF-924 and 954-LVTKDIDFD-963, were recognized, which presumably are of paramount importance for docking of the virus to host cell receptors. A consensus motif 916-KVXATIXSF-924 could be identified by mutational analysis. The neutralizing antibodies to the most widely distributed hantaviruses causing HFRS might be promising candidates for the development of an agent for prevention and treatment of HFRS in patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12706090     DOI: 10.1016/s0042-6822(02)00094-6

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  26 in total

Review 1.  Lepidopteran cells, an alternative for the production of recombinant antibodies?

Authors:  Martine Cérutti; Josée Golay
Journal:  MAbs       Date:  2012-04-26       Impact factor: 5.857

2.  Interactions and oligomerization of hantavirus glycoproteins.

Authors:  Jussi Hepojoki; Tomas Strandin; Antti Vaheri; Hilkka Lankinen
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

3.  Maternally derived recombinant human anti-hantavirus monoclonal antibodies are transferred to mouse offspring during lactation and neutralize virus in vitro.

Authors:  Shuyang Yu; Mifang Liang; Baoliang Fan; Hongtao Xu; Chuan Li; Quanfu Zhang; Dexin Li; Bo Tang; Shijie Li; Yunping Dai; Meili Wang; Min Zheng; Bingxue Yan; Qinghong Zhu; Ning Li
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

Review 4.  New ecological aspects of hantavirus infection: a change of a paradigm and a challenge of prevention--a review.

Authors:  Martin Zeier; Michaela Handermann; Udo Bahr; Baldur Rensch; Sandra Müller; Roland Kehm; Walter Muranyi; Gholamreza Darai
Journal:  Virus Genes       Date:  2005-03       Impact factor: 2.332

5.  Highly differentiated, resting gn-specific memory CD8+ T cells persist years after infection by andes hantavirus.

Authors:  Tobias Manigold; Andrés Mori; Rebecca Graumann; Elena Llop; Valeska Simon; Marcela Ferrés; Francisca Valdivieso; Constanza Castillo; Brian Hjelle; Pablo Vial
Journal:  PLoS Pathog       Date:  2010-02-19       Impact factor: 6.823

6.  Human antibody neutralizes severe Fever with thrombocytopenia syndrome virus, an emerging hemorrhagic Fever virus.

Authors:  Xiling Guo; Li Zhang; Wenshuai Zhang; Ying Chi; Xiaoyan Zeng; Xian Li; Xian Qi; Qiu Jin; Xiao Zhang; Mingming Huang; Hua Wang; Yin Chen; Changjun Bao; Jianli Hu; Shuyi Liang; Lin Bao; Tao Wu; Minghao Zhou; Yongjun Jiao
Journal:  Clin Vaccine Immunol       Date:  2013-07-17

7.  Monitoring Neutralization Property Change of Evolving Hantaan and Seoul Viruses with a Novel Pseudovirus-Based Assay.

Authors:  Tingting Ning; Ling Wang; Shuo Liu; Jian Ma; Jianhui Nie; Weijin Huang; Xuguang Li; Yuhua Li; Youchun Wang
Journal:  Virol Sin       Date:  2020-06-12       Impact factor: 4.327

8.  Expression and characterization of a soluble form of tomato spotted wilt virus glycoprotein GN.

Authors:  Anna E Whitfield; Diane E Ullman; Thomas L German
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

9.  Broad and potently neutralizing monoclonal antibodies isolated from human survivors of New World hantavirus infection.

Authors:  Taylor B Engdahl; Natalia A Kuzmina; Adam J Ronk; Chad E Mire; Matthew A Hyde; Nurgun Kose; Matthew D Josleyn; Rachel E Sutton; Apoorva Mehta; Rachael M Wolters; Nicole M Lloyd; Francisca R Valdivieso; Thomas G Ksiazek; Jay W Hooper; Alexander Bukreyev; James E Crowe
Journal:  Cell Rep       Date:  2021-05-04       Impact factor: 9.423

Review 10.  Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy.

Authors:  Kristian Daniel Ralph Roth; Esther Veronika Wenzel; Maximilian Ruschig; Stephan Steinke; Nora Langreder; Philip Alexander Heine; Kai-Thomas Schneider; Rico Ballmann; Viola Fühner; Philipp Kuhn; Thomas Schirrmann; André Frenzel; Stefan Dübel; Maren Schubert; Gustavo Marçal Schmidt Garcia Moreira; Federico Bertoglio; Giulio Russo; Michael Hust
Journal:  Front Cell Infect Microbiol       Date:  2021-07-07       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.